| 000 | 01646 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518012757.0 | ||
| 264 | 0 | _c20190903 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1873-2968 | ||
| 024 | 7 |
_a10.1016/j.bcp.2018.12.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAskari, Vahid Reza | |
| 245 | 0 | 0 |
_aPromising neuroprotective effects of β-caryophyllene against LPS-induced oligodendrocyte toxicity: A mechanistic study. _h[electronic resource] |
| 260 |
_bBiochemical pharmacology _c01 2019 |
||
| 300 |
_a154-171 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCannabinoids _xpharmacology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 |
_aLipopolysaccharides _xtoxicity |
| 650 | 0 | 4 |
_aNF-E2-Related Factor 2 _xmetabolism |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aOligodendroglia _xdrug effects |
| 650 | 0 | 4 |
_aPPAR gamma _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPolycyclic Sesquiterpenes |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, Cannabinoid, CB1 _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, Cannabinoid, CB2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSesquiterpenes _xpharmacology |
| 650 | 0 | 4 |
_aSphingomyelin Phosphodiesterase _xantagonists & inhibitors |
| 700 | 1 | _aShafiee-Nick, Reza | |
| 773 | 0 |
_tBiochemical pharmacology _gvol. 159 _gp. 154-171 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bcp.2018.12.001 _zAvailable from publisher's website |
| 999 |
_c29142506 _d29142506 |
||